Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with fibrotic interstitial lung disease (a type of scarring lung condition), of any specific subtype, whether currently receiving treatment or having received treatment in the past
- People who have more than 10% scarring visible on a CT scan of the lungs
- People who experience at least a moderate level of breathlessness in daily life, as measured by a standard questionnaire (confirm with trial site for exact score details)
- People of any racial or ethnic background, including those who do not speak English (professional translators will be provided to help throughout the study)
Who may not be able to join:
- People who are unable to walk due to a physical condition affecting the bones, joints, nervous system, or heart
- People who have difficulty understanding or following instructions due to cognitive impairment
- People who have completed a traditional, centre-based pulmonary rehabilitation program within the 3 months before being considered for the study
- People who are receiving hospice or end-of-life care at the time of their screening assessment
- People who are experiencing a sudden and significant worsening of their lung condition at the time of their screening assessment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Teng Moua, Mayo Clinic
Phone: 507-293-1989
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
King's Brief Interstitial Lung Disease (K- BILD); Physical activity as measured by change in mean number of steps per day
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.